AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2024

Nov 22, 2024

30071_dirs_2024-11-22_8e932e0f-124e-4904-a0f1-42558c9bfd63.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2024-11-20

Reporting Person: Gill Harjit (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-20	ResMed Common Stock	A	1083	—	Acquired	9905	Direct

Footnotes

F1: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2025, or the annual shareholder's meeting in the year following the grant date.